NeuBase Therapeutics OverviewNeuBase Therapeutics Other Income Expense Net
Other Income/Expense Net for NBSE.
Quarterly Other Income/Expense
$992064.00
↑ 984.31% YoY
As of Sep 30, 2023
Annual Other Income/Expense (TTM)
$1.42M
↑ 419.78% YoY
Trailing 12 months ending Sep 30, 2023